Table 1.
Compound | Spectral Response in TCCYP51 |
Effect on enzymatic activity (I/E2****) |
|||
---|---|---|---|---|---|
Type | Soret band maximum, nm | Kd, μM | TCCYP51 | Mouse COX2 | |
5 | 2 | 422 | 0.44±0.02 | 10 | |
7 | 2 | 422 | 0.75±0.03 | 14 | |
9 | 2 | 422 | 0.24±0.01 | <1 | |
12 | 2 | 422 | 0.29±0.01 | 9.1 | 2.1 |
13 | 2** | 418 | 7.6±0.9 | 13 | >10 |
14 | 2 | 422 | 0.54±0.02 | 10 | 10 |
15 | 2 | 422 | 0.37±0.05 | 8.5 | 1.7 |
16 | 1* | 416 | 3.3±0.48 | 11 | 2.1 |
17 | none | 417 | - | 15 | 3.6 |
19 | 2** | 420 | 0.56±0.08 | 7.7 | <1 |
18 | 2** | 420 | 0.26±0.04 | 4.2 | <1 |
20 | 2*** | 422 | 2.31±0.09 | 6.3 | 2.4 |
21 | 2** | 419 | 0.36±0.02 | <1 | <1 |
22 | 2** | 419 | 0.15±0.01 | <1 | >40 |
weak type 1 response with only ~7% of P450 experiencing low to high spin transition;
modified type 2 response with the smaller shift in the Soret band maximum,
sigmoid curve, Hill coefficient 2.3±0.2 (see Figure 2);
inhibitory potencies of the compounds toward TCCYP51 (minimal final concentration required in the reconstituted reaction 1 μM9) and mouse COX2 (final concentration 0.1 μM) are compared as molar ratios Inhibitor/Enzyme which cause a two-fold decrease in the initial rate of catalysis.